jrnl5173

Publication Venue For

  • Behavioral therapy for urinary symptoms in Parkinson's disease: A randomized clinical trial.  38:1737-1744. 2019
  • Terminology for bladder health research in women and girls: Prevention of Lower Urinary Tract Symptoms transdisciplinary consortium definitions.  38:1339-1352. 2019
  • Impact of age on mid- to long-term outcomes of transvaginal native tissue repair for apical vaginal prolapse.  37:2860-2866. 2018
  • Occupation and lower urinary tract symptoms in women: A rapid review and meta-analysis from the PLUS research consortium.  37:2881-2892. 2018
  • The Prevention of Lower Urinary Tract Symptoms (PLUS) in girls and women: Developing a conceptual framework for a prevention research agenda.  37:2951-2964. 2018
  • Analysis of cost of component replacement versus entire device replacement during artificial urinary sphincter revision surgery.  37:1931-1936. 2018
  • Increased odds of bladder and bowel symptoms in early Parkinson's disease.  37:1344-1348. 2018
  • Metabolites and microbial composition of stool of women with fecal incontinence: Study design and methods.  37:634-641. 2018
  • Urinary incontinence and hydration: A population-based analysis.  37:200-205. 2018
  • Hydrodistention of the bladder for the treatment of bladder pain syndrome/interstitial cystitis (BPS/IC).  36:784-786. 2017
  • Efficacy and safety of onabotulinumtoxinA therapy are sustained over 4 years of treatment in patients with neurogenic detrusor overactivity: Final results of a long-term extension study.  36:368-375. 2017
  • The relationship between fecal incontinence, constipation and defecatory symptoms in women with pelvic floor disorders.  36:495-498. 2017
  • Psychometric evaluation of an online and paper accidental bowel leakage questionnaire: The ICIQ-B questionnaire.  36:166-170. 2017
  • Management of recurrent stress urinary incontinence after burch and sling procedures.  35:344-348. 2016
  • Conservative management for female urinary incontinence and pelvic organ prolapse review 2013: Summary of the 5th International Consultation on Incontinence.  35:15-20. 2016
  • Pelvic-floor-muscle-training adherence "modifiers": A review of primary qualitative studies - 2011 ICS State-of-the-Science Seminar research paper III of IV.  34:622-631. 2015
  • Urinary incontinence in frail elderly persons: Report from the 5th international consultation on incontinence.  34:398-406. 2015
  • Comparison of flowrates and voided volumes during non-instrumented uroflowmetry and pressure-flow studies in women with stress incontinence.  34:549-553. 2015
  • The minimum important difference for the International consultation on incontinence questionnaire - Urinary incontinence short form in women with stress urinary incontinence.  34:183-187. 2015
  • Pre-operative urodynamics in women with stress urinary incontinence increases physician confidence, but does not improve outcomes.  33:302-306. 2014
  • Sacral neuromodulation effects on periurethral sensation and urethral sphincter activity.  32:476-479. 2013
  • Association of Baseline urodynamic measures of urethral function with clinical, demographic, and other urodynamic variables in women prior to undergoing midurethral sling surgery.  31:496-501. 2012
  • Perineal surface electromyography does not typically demonstrate expected relaxation during normal voiding.  30:1591-1596. 2011
  • Minimum important difference for validated instruments in women with urge incontinence.  30:1319-1324. 2011
  • Further validation of the short form versions of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ)..  30:541-546. 2011
  • The role of urgency, frequency, and nocturia in defining overactive bladder adaptive behavior.  30:406-411. 2011
  • Mixed incontinence: Comparing definitions in non-surgical patients.  30:47-51. 2011
  • REDUCTION OF RADIATION DURING FLUORO URODYNAMICS: AN ANALYSIS OF A QUALITY ASSURANCE PROTOCOL LIMITING FLUOROSCOPIC IMAGES DURING FLUORO URODYNAMIC STUDIES.  30:253-253. 2011
  • Genome-based expression profiling study following spinal cord injury in the rat: An array of 48-gene model.  29:1439-1443. 2010
  • Patient satisfaction with stress incontinence surgery.  29:1403-1409. 2010
  • Urodynamics, the supine empty bladder stress test, and incontinence severity.  29:1306-1311. 2010
  • Predictors of variability in urinary incontinence and overactive bladder symptoms.  29:328-335. 2010
  • The questionnaire for urinary incontinence diagnosis (QUID): Validity and responsiveness to change in women undergoing non-surgical therapies for treatment of stress predominant urinary incontinence.  29:726-733. 2010
  • Challenges of conducting multi-center, multi-disciplinary urinary incontinence clinical trials: Experience of the Urinary Incontinence Treatment Network.  28:170-176. 2009
  • Mixed incontinence: Comparing definitions in women having stress incontinence surgery.  28:268-273. 2009
  • Randomized comparison of tolterodine with vaginal estrogen cream versus tolterodine alone for the treatment of postmenopausal women with overactive bladder syndrome.  28:47-51. 2009
  • Postvoid residual urine in women with stress incontinence.  27:48-51. 2008
  • Global ratings of patient satisfaction and perceptions of improvement with treatment for urinary incontinence: Validation of three global patient ratings.  25:411-417. 2006
  • Changes in detrusor smooth muscle myosin heavy chain mRNA expression following spinal cord injury in the mouse.  24:89-95. 2005
  • Outcome measures for research of lower urinary tract dysfunction in frail older people.  17:273-281. 1998
  • The relationship between external anal and external urethral sphincter activity in continent women.  10:555-562. 1991
  • Pelvic floor muscle exercise for the treatment of female stress urinary incontinence: III. Effects of two different degrees of pelvic floor muscle exercises.  9:489-502. 1990